A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
Clinical trial NCT06769048 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06769048
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-31
- Primary completion
- 2026-12-25
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.